secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0001493152-23-034907
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics receives Nasdaq delisting notice for bid price non-compliance
----------------------------------------------------------------------------

- Received Nasdaq staff determination to delist due to failure to maintain $1.00 minimum bid price.
- Company plans to request a hearing before Nasdaq Hearings Panel to appeal the delisting determination.
- Company is evaluating alternatives to regain compliance; no assurance of success.
- If delisted, securities expected to trade on OTC Markets platform.
- Company previously under mandatory Panel Monitor, making it ineligible for standard compliance period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223034907/0001493152-23-034907-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223034907/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-034907

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer